Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 06 Mar 2023
USA: The syrup drug Diethylene glycol (DEG), a drug commonly used to prevent infections, is the cause of kidney disease...
Read Full NewsIn this Neuropathways piece, Kevin Chang, PharmD, explores the complexities of remyelination in multiple sclerosis and the potential of Wnt/β-catenin signaling as a therapeutic target.
Test your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of clinical and historical neurology topics. This week's topic is on RBD as a prodromal marker for synucleinopathies!
Psoriatic Arthritis in 2025: Year in Review
Reframing Fibromyalgia Care in 2025: Restricted Impact of TNX-102 SL’s Approval
1.
Obesity-associated cancers tripled nationwide over past two decades
2.
Unexplained CAR-T Death; Americans Spurn Sunscreen; Improving Diversity in Trials
3.
Detecting pancreatic cancer through changes in body composition and metabolism
4.
Pirtobrutinib May Be Beneficial in Follicular Lymphoma with Severe Pretreatment.
5.
Cancer tumor anatomy influences the benefits of chemotherapy for patients with early-stage breast cancer.
1.
The Link Between Being Overweight and Cancer
2.
A Closer Look at Poorly Differentiated Carcinoma: Uncovering its Complexities
3.
What Is Gastrinoma? Understanding This Rare Tumor and Its Treatment Options
4.
Cancer Diagnosis in 2025: Innovations, Education, and Evolving Clinical Strategies
5.
Carboplatin Treatment: What You Need to Know About Side Effects and Efficacy
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
CNS Clarity from Day One: Rethinking Early Diagnostic Strategies in ALK+NSCLC
2.
Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL
3.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases - Part II
4.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part IV
5.
Navigating the Complexities of Ph Negative ALL - Part XIV
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge